Personalized Functional Profiling

DIAGNOSTIC_TEST2 trials

Sponsors

Luxembourg Institute of Health

Conditions

Colorectal CancerOncologyPDAC - Pancreatic Ductal Adenocarcinoma

Unknown Phase

Personalized Functional Profiling in Metastatic Gastrointestinal Cancer or Recurrent Glioblastoma Patients in Luxembourg.

CompletedNCT03997617

Luxembourg Institute of HealthOncology

Start: 2019-03-11End: 2024-12-31Updated: 2025-06-13

Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC

RecruitingNCT07500259

Luxembourg Institute of HealthColorectal Cancer, PDAC - Pancreatic Ductal Adenocarcinoma

Start: 2026-09-11End: 2034-11-01Target: 188Updated: 2026-09-15